NCT05014204: A trial that was reported late by Endogenex, Inc.
This trial has reported, although it was 135 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05014204 |
|---|---|
| Title | Safety and Feasibility of Endoscopic Application of a Novel Therapy for Duodenal Mucosal Regeneration in the Treatment of Type II Diabetes |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 29, 2021 |
| Completion date | May 26, 2024 |
| Required reporting date | May 26, 2025, midnight |
| Actual reporting date | Oct. 8, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 135 |